Alzheimer's Mice Show Brain Energy and Oxygen Both Altered

University of Virginia researchers have measured, in the same living mice, how brain cells make energy and how much oxygen their blood vessels carry, and found both altered in an Alzheimer's model. ^[1]

The study, titled "Metabolism and oxygen tension in Alzheimer's disease mouse model using two-photon FLIM-PLIM microscopy," appeared in the journal Neurophotonics in 2026. ^[1][2] It comes from the group of Ammasi Periasamy, who compared mice that model Alzheimer's disease with wild-type mice, the ordinary animals without the disease modification. ^[1]

The team looked at the cerebral cortex, the brain's outer layer, while the animals lay anesthetized and at rest. The Alzheimer's model mice showed a higher protein-bound fraction of a molecule called NAD(P)H, which the researchers use as a gauge of mitochondrial activity. They also showed lower oxygen pressure in the cortical blood vessels. ^[1]

Two problems, one window

The brain is a hungry organ. Its cells run on energy made in mitochondria, the small structures that act as a cell's power stations, and that work depends on oxygen delivered by blood. Metabolism and oxygen supply are tied together, yet according to co-author Andrés Norambuena they are often investigated separately. ^[1]

Measure one alone and you can see that something has changed, but not how it relates to the other. That gap is what the new method is built to close. Norambuena said the findings suggest that changes in cellular energy metabolism and oxygen use can be detected at the same time in the living Alzheimer's mouse brain. ^[1]

How the two lights work

The method pairs two techniques. The first, fluorescence lifetime imaging microscopy, or FLIM, reads the faint glow that NAD(P)H gives off naturally when light hits it. ^[1] That glow fades within a tiny fraction of a second, and how fast it fades depends on whether the molecule is bound to a protein. The researchers took the share of protein-bound NAD(P)H as an indicator of how active the mitochondria are. ^[1]

The second, phosphorescence lifetime imaging microscopy, or PLIM, relies on a ruthenium-based probe that is sensitive to oxygen. Its afterglow changes with the oxygen around it, which lets the team estimate the partial pressure of oxygen, a measure of how much oxygen is available, across the brain's network of blood vessels. ^[1]

Both run through a two-photon microscope, a design that images deep into living tissue. ^[1] The result is a metabolic signal from the cells and an oxygen reading from the vessels around them, taken together rather than in separate experiments.

Why doing both at once is hard

Periasamy said the simultaneous measurement demanded precise synchronization between a Zeiss two-photon microscope and the lifetime-imaging electronics from Becker & Hickl. ^[1] It also demanded careful calibration and stable conditions, including the animals' body temperature and level of anesthesia. ^[1]

The stability matters because both signals can drift with the state of the animal. If the temperature or the depth of anesthesia wanders, a change in either reading could come from the setup rather than from the disease. Holding those conditions steady is what lets the group compare model mice with wild-type mice at all.

What the numbers are read to mean

The researchers interpret the lower vascular oxygen in the Alzheimer's model as evidence of greater oxygen consumption. ^[1] Read alongside the higher bound fraction of NAD(P)H, the picture is of cortical tissue working its mitochondria harder and drawing down the oxygen in nearby vessels.

That reading is the team's interpretation. Other factors could also lower oxygen in the vessels, and the work has not yet ruled them out.

The limits are plain. This was done in mice, and it does not establish that the same metabolic and oxygen patterns occur in people with Alzheimer's disease. ^[1] The account of the study does not give the number of animals in each group. ^[1]

It also does not show that the imaging can spot the disease before symptoms appear, predict how it will progress, or point to a treatment. The mice were measured at rest, and the researchers have not yet reported how the readings change across stages of disease or when brain activity is pushed up by a task. ^[1]

Why a new way of looking matters

The study's contribution is the tool. Much of the interest in the brain's energy supply in Alzheimer's rests on a chicken-and-egg question: does energy failure come first, or does a failing oxygen supply? Answering it needs both signals measured in the same animal, at the same moment, and then followed over time. This combination is built for that job, even though this first paper does not yet do it.

That is my judgement of where the value lies, and not a claim the authors make. What they report is narrower and firmer. In a living Alzheimer's model, metabolism and oxygen can be watched changing together, and both differ from healthy animals at rest. ^[1]

The next tests are the ones the study leaves open. They include whether the pattern appears early in the disease or only late, whether it holds when the brain is stimulated, and whether anything like it shows up in people. No such results have been reported so far.

For now the finding sits where most good basic science sits, a clear measurement in a mouse and a list of questions that only more mice, and eventually people, can answer.